Product Description: HPK1-IN-40 (compound 49) is a potent and selective HPK1 inhibitor with an IC50 of 0.9 nM. HPK1-IN-40 reinvigorates T-cell receptor (TCR) signaling, promoting T-cell function and cytokine production in T cells while having anti-cancer activity[1].
Applications: COVID-19-immunoregulation
Formula: C24H20D2FN7O3
References: [1] Jing Ai, et al. Design, Synthesis, and Pharmacological Evaluation of Isoindoline Analogues as New HPK1 Inhibitors. Journal of Medicinal Chemistry. 2023,Article ASAP.
Molecular Weight: 477.49
Research Area: Cancer; Inflammation/Immunology
Solubility: 10 mM in DMSO
Target: MAP4K